National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
100 Years of Advances Against Cancer
    Updated: 11/03/2008



100 Years of Advances Against Cancer






1900s-1930s






1940s-1950s






1960s






1970s






1980s






1990s






2000s



Page Options
View Entire Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

NCI Launches Community Cancer Centers Pilot

The Nation's Investment in Cancer Research FY 2009

NCI Strategic Plan for Leading the Nation

NCI Training and Career Development Inventory

Cancer Trends Progress Report: 2007 Update

NCI Participation in the NIH Roadmap

Past Highlights
100 Years of Advances Against Cancer - 1980s

1980s

The first highly effective anti-nausea drugs are developed to alleviate this side effect of chemotherapy.

Continuous pain medication infusion pumps are developed.

Biochemical and genetic assays are integrated into epidemiologic studies (molecular epidemiology).

Magnetic resonance imaging (MRI) is introduced in the early 1980s.

Severe combined immunodeficiency (SCID) mice are developed in the mid-1980s. These mice play an important role in cancer research.

1980 NCI scientists isolate human T-cell lymphotrophic virus 1 (HTLV-1). This virus, which is also called adult T-cell leukemia virus, is the causative agent of adult T-cell leukemia/lymphoma (ATLL) and several other diseases.
1981 The first human viral vaccine that can prevent cancer (hepatitis B virus vaccine for liver cancer) is introduced.
1982 The first major DNA sequence databases are established in the United States (GenBank) and Germany.

NCI's Physician Data Query (PDQ) cancer information database goes online. PDQ is made available through a dial-up connection to the U.S. National Library of Medicine.
1983 The restriction fragment length polymorphism (RFLP) technique, which is a DNA analysis technique, is used in cancer research.

Computerized tomography of the colon (virtual colonoscopy) is proposed as a screening method to identify colon polyps and colorectal cancer.
1984 Dietary guidelines to reduce cancer are introduced.

The human p53 gene is cloned.
1985 Lumpectomy plus radiation therapy is found equivalent to mastectomy for early breast cancer.

The polymerase chain reaction technique (PCR) is introduced. This technique allows millions of copies of an individual segment of DNA to be made from a single copy.

Nerve-sparing prostatectomy, designed to preserve potency and urinary continence, is introduced.
1986 The human HER2 proto-oncogene is cloned. HER2 is also called neu and erbB2.
1987 The human retinoblastoma (Rb) gene is cloned. Rb is a tumor-suppressor gene associated with the pediatric eye cancer retinoblastoma.
1988 Post-operative (adjuvant) chemotherapy is proven to increase disease-free survival in women with early breast cancer.

The Bethesda System Conference develops a system for standardized reporting of Pap smear results.
1989 Adjuvant chemotherapy is proven to increase survival in colon cancer.

The Human Gene Mapping database is established.

Carboplatin, a drug related to cisplatin, is approved by the Food and Drug Administration.

Certification in radiation oncology is first offered.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov